The intramolecular Diels-Alder (IMDA) reaction, a \[4π+2π\] cycloaddition, is one of the most widely utilized reactions for preparing ring systems.^[@R1]--[@R10]^ According to how the diene motif is tethered to the dienophile, IMDA reactions are classified into two types: type I and type II.^[@R7]^ While vast success has been achieved for applying type I-IMDA (tethered at the 1-position of the diene) in fused-ring syntheses, in contrast, much limited scaffolds can be prepared by type II-IMDA (tethered at the 2-position of the diene) due to Bredt's rule^[@R11]^ (unfavorable *sp^2^* carbon at the bridge-head position). For example, while 6--6 and 5--6 bridged rings are commonly found in various bioactive molecules ([Fig. 1a](#F1){ref-type="fig"}), formation of 6--6 bridged rings (\[3.3.1\]-bicycle) via type II-IMDA was mainly restricted in gas phase^[@R12]--[@R14]^ and to our knowledge, no 5--6 bridged rings (\[3.2.1\]-bicycle) has been observed to date using such an approach ([Fig. 1b](#F1){ref-type="fig"}). Stimulated by the challenge of type II-IMDA, in this communication, we describe an alternative \[4+2\] coupling method that is capable of providing type II-IMDA-like products via a cooperative C--C bond activation of cyclobutanones. Using this methodology, a complementary scope of bridged skeletons, including a variety of 6--6 and 5--6 bridged rings, can be accessed; furthermore, the ketone group of the products can serve as a convenient handle to access other functional groups or ring systems.

Results and discussion {#S1}
======================

C--C bond activation/functionalization recently merged a useful method for synthesizing complex scaffolds from relatively simpler starting materials.^[@R15]--[@R29]^ In particular, bridged-ring synthesis can be benefited by this strategy. The intramolecular insertion of alkynes into benzocyclobutendione C--C bonds was first reported by Liebeskind using a stoichiometric Co-complex ([Fig. 1c](#F1){ref-type="fig"}).^[@R30]^ Seminal work by Murakami/Ito described intramolecular insertions of styrene-type olefins into cyclobutanones catalyzed by either cationic Rh^1^ or Ni^0^, albeit limited to benzo-fused skeletons ([Fig. 1c](#F1){ref-type="fig"}).^[@R31]--[@R32]^ One key challenge for developing cyclobutanone-olefin couplings via metal-mediated oxidative addition into C--C bonds is the competing decarbonylation reaction ([Fig. 1c](#F1){ref-type="fig"}), which leads to either ring contraction or fragmentation (for cyclobutanone activations via β-carbon elimination, see refs 32--39).^[@R31]^ Therefore, in order to develop a general cyclobutanone-olefin coupling that is broadly applicable for synthesizing bridged type II-IMDA-like products, the decarbonylation challenge has to be overcome and the scope of the olefin substrates (e.g. both aryl and alkyl substituted alkenes) as well as the variety of the bridged-scaffolds must be extended.

Our strategy is inspired by a "cofactor"-assisted C--C activation mode initially developed by Jun,^[@R40]--[@R42]^ which utilizes 2-amino-3-methylpyridine as a co-catalyst to generate an imine intermediate that serves as a directing group for cleaving the imine α C--C bond. This strategy has been effectively utilized to cleave medium to large cyclic ketimines in the presence of alkenes to afford ring-opened products ([Fig. 1c](#F1){ref-type="fig"}). However, to the best of our knowledge, *utilization of this mode in small-ring activation has not been reported previously*. We hypothesized that employment of 2-amino-3-methylpyridine as a co-catalyst would benefit the desired intramolecular cyclobutanone-olefin coupling, depicted in [Fig. 2](#F2){ref-type="fig"}. The amine would first form an imine with the cyclobutanone, which would then direct C--C cleavage through forming a chelation complex with the metal (e.g. Rh). Subsequent olefin migratory insertion followed by reductive elimination is expected to provide the bridged scaffold and regenerate the metal catalyst. Finally, the resulting imine can be hydrolyzed to give the bridged-ketone product and 2-amino-3-methylpyridine, which can be recycled. Hence, this strategy, distinct from the previous cyclobutanone activations,^[@R31]--[@R32],\ [@R28]^ can ease the C--C cleavage but more importantly prevent the aforementioned decarbonylation problem, because the carbonyl group would be *[in situ]{.ul}* protected by the imine formation. Moreover, in principle, both the transition metal and the aminopyridine can be catalytic.

To test our hypothesis, cyclobutanone **1a** was used as the model substrate, which was readily prepared in three steps from inexpensive commercially available materials. In the presence of 3-methyl-2-aminopyridine (**3**), a variety of Rh precatalysts, ligands and solvents were examined (for details, see supplementary information). The conditions (cationic Rh with dppp) that gave the best results in the previous example ([Fig. 1c](#F1){ref-type="fig"}, Murakami/Ito)^[@R31]^ did not provide any of the desired bicycle (entry 1, [Table 1](#T1){ref-type="table"}). However, \[Rh(COD)Cl\]~2~ was found to be a promising precatalyst and the desired bridged bicycle (3-azabicyclo\[3,3,1\]nonanone) **2a**^[@R43]--[@R47]^ was obtained albeit in low yields (entry 2). The solvent effect was next evaluated and 1,4-dioxane proved to be the best solvent (entries 3--5). While the yield of bicycle **2a** can be improved by adding more COD ligand (entry 6), employment of a monodentate electron-deficient phosphine ligand was found more effective likely due to that the migratory insertion and reductive elimination steps can be accelerated with more π-acidic ligands (entries 7--9). Use of bidentate ligands, such as dppp and dppb, showed no catalytic activity. \[Rh(COD)Cl\]~2~ (10 mol %) with P(3,5-C~6~H~3~(CF~3~)~2~)~3~ (22 mol %) was found to give full conversion with an 82% isolated yield of product **2a** (entry 9). Use of a catalytic amount of cofactor **3** (20 mol %) is also feasible albeit giving a slightly lower yield (76%) with extended reaction time (entry 10). Ultimately, use of 5 mol% \[Rh(C~2~H~4~)~2~Cl\]~2~ (10 mol% total on Rh) and 24 mol% P(3,5-C~6~H~3~(CF~3~)~2~)~3~ provided aza\[3,3,1\]nonanone **2a** in 87% isolated yield (entry 11).

The use of cofactor **3** was critical. In the absence of **3**, no \[4+2\] product was observed; decarbonylation products and the Rh-carbonyl complex (a dead catalyst, see supplementary information) can be detected by LCMS, HRMS and ^1^H-NMR (entry 12). This control experiment strongly supports our hypothesis that decarbonylation can be inhibited by using 2-amino-3-methylpyridine (*vide supra*). The structure of bridged-bicycle **2a** was unambiguously confirmed by ^1^H, ^13^C NMR, IR, HRMS and X-ray crystallography. Given that the nitrogen-containing scaffold was obtained when the nitrogen-tether was employed, we expect this method can potentially be useful for alkaloid synthesis ([Fig. 1a](#F1){ref-type="fig"}).

With the optimized conditions in hand, we next investigated the substrate scope ([Table 2](#T2){ref-type="table"}). In general, cyclobutanones tethered with 1,1-disubstituted olefins were converted into the corresponding 3-azabicyclo\[3,3,1\]nonanones smoothly. Not surprisingly, increasing the steric bulk on the olefin substituent from methyl to isopropyl to cyclopentyl slowed the reaction (entries 1--5), but the desired bridged bicycles were all nevertheless obtained in good to modest yields. Monosubstituted olefins can also insert into the C--C bond of cyclobutanones efficiently (entries 6 and 7). Changing the protecting group on the nitrogen from Ts to carbamate (CO~2~Me) did not significantly affect the reactivity (entry 7 vs 6). Aryl-substituted olefins were found to be more challenging substrates likely due to their stability issue under the reaction conditions; nevertheless, it is encouraging to note that they can still participate in this transformation, albeit with relatively lower efficiency. The more electron-rich aryl olefins provided much higher yields than the corresponding electron-poor substrates (entries 8--10). Changing the quaternary carbon substitution (from Me to Et) on cyclobutanones did not significantly affect the reactivity (entry 11).

Both *cis* and *trans*-disubstituted olefins are suitable substrates, and higher reactivity was observed with the *cis* substrate (entries 12 and 13). Both substrates **1l** and **1m** provided the products with the same diastereomeric ratio (dr), probably due to an enamine equilibration. Besides forming 6--6 bridged \[3.3.1\] systems, the 5--6 bridged \[3.2.1\] scaffolds can also be obtained using this strategy. The vinyl sulfonamide **1n** can participate to give the desired bridged ring (**2n**) (entry 14). In addition, substrates with all-carbon linkages were also found suitable (entries 15 and 16). It is interesting to note that with **1o** as the substrate, a stable enamine derivative of **2o** (with 2-amino-3-methylpyridine **3)** can be isolated as the major product, which was confirmed by X-ray crystallography (see supplementary information). Subsequent hydrolysis with diluted acetic acid provided the ketone **2o** in 54% (81% brsm) yield (entry 15). The substrate with an arene linkage (**1p**)^[@R31]^ provided the desired benzo-bicycle (**2p**) in nearly a quantitative yield under the standard conditions, suggesting a potentially broad substrate scope (entry 16).

Substrate **1q** with a spirocyclic center was also investigated for this transformation ([Fig. 3a](#F3){ref-type="fig"}). Two diastereomers of the desired product were obtained due to the diastereotopic difference between the two α-C--C bonds. The products **2q-i** and **2q-ii** contain interesting tricyclic bridged and fused scaffolds, which have been found in a number of aconitum/delphinium alkaloids ([Fig. 1a](#F1){ref-type="fig"}, *vide supra*). Structures of both products were unambiguously confirmed by X-ray crystallography of their 2,4-dinitrophenylhydrazone derivatives (see supplementary information). Furthermore, preliminary studies have revealed that chiral phosphoramidite ligands, such as **4**, effect the desymmetrization of cyclobutanone **1b** with promising levels of enantioselectivity ([Fig. 3b](#F3){ref-type="fig"}, 37% ee).^[@R48]--[@R49]^ This result suggests that the "cofactor"-assisted C--C activation mode is amenable to asymmetric catalysis, and work on this topic is ongoing.

Finally, we demonstrated the carbonyl group in the formed bridged bicycles can serve as a convenient handle to access other ring systems through either ring contraction or expansion ([Fig. 3c](#F3){ref-type="fig"}). Treatment of **2a** under Baeyer--Villiger oxidation conditions gave the α-chloroketone unexpectedly. Subsequent Favorskii rearrangement afforded the ring-contraction product (**6**) in 78% yield. Oxime formation followed by Beckmann rearrangement provided the ring-expansion product (7--6 bridged amide, **8**) uneventfully.

Conclusion {#S2}
==========

In summary, we have developed a unique strategy to enable a "saturated analogue" of type II-IMDA reaction between cyclobutanones and simple alkenes via a Rh-catalyzed "cofactor"-assisted C--C activation approach. Substrates with different tethers and olefin substitutions (both aryl and alkyl alkenes) underwent this transformation. The resulting ketone bicycles can be readily further functionalized through carbonyl chemistry. While sharing a common feature to form 6-membered rings, this approach can provide scaffolds that are difficult to prepare using conventional IMDA reactions. Another advantage is that unactivated alkyl or aryl-substituted alkenes, instead of Michael acceptors (typically used in type-II IMDA)^[@R7]^, can be used as coupling partners. We expect the strategy developed here may provide inspirations for designing new tactics to synthesize complex natural products and other bioactive molecules.

Methods {#S3}
=======

In a nitrogen filled glove box, a 1-dram vial was charged with \[Rh(C~2~H~4~)~2~Cl\]~2~ (1.9 mg, 5 mol%), tris\[3,5-bis(trifluoromethyl)phenyl\]phosphine (16 mg, 24 mol%) and 2-amino-3-picoline (10 μl, 0.1 mmol). A solution of starting material **1a** (32 mg, 0.1 mmol) in dioxane (1 ml, 0.1 M) was added and the 1-dram vial was capped and the solution was maintained at 152 °C for 48 h. The reaction was removed from the glove box and purified by flash chromatography. The product **2a** was obtained as a bright orange solid (28 mg, 87%). The procedure to prepare compound **2a** is generally representative for all the products shown in [Table 2](#T2){ref-type="table"}. Any deviations from this protocol are specified in the footnote of the table.
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![The challenge of bridged-ring synthesis\
**a**, Selected alkaloid natural products with bridged-ring substructures. **b**, Comparison of the type II IMDA reaction - which is synthetically limited by the incipient strain in an unsaturated bridgehead carbon - and the approach described in this work. **c**, Previous work on metal-catalysed C−C activation of cyclobutanones towards coupling and potential challenges due to the decarbonylation of the ketones.](nihms600160f1){#F1}

![Proposed catalytic cycle\
The key features include using metal-ligand cooperative activation of cyclobutanones and *in situ* carbonyl group protection to avoid decarbonylation.](nihms600160f2){#F2}

![Potentials and applications in bridged-ring synthesis\
**a**, Construction of fused-bridged tricyclic structures. **b**, Potentials for developing an enantioselective transformation. **c**, Use of the carbonyl group in the product as a handle to access ring-contracted and expanded bridged rings.](nihms600160f3){#F3}

###### 

Selected optimization studies

  ---- --------------------------------------------------------- ----------------------------------------------------------------- ----------------- --------- ----------------------------------
  1    5 mol%\                                                   10 mol%\                                                          Xylenes           130       0
       \[Rh(nbd)dppp\]PF~6~                                      BHT                                                                                           

  2    10 mol%\                                                                                                                    Toluene           130       \<5
       \[Rh(COD)Cl\]~2~                                                                                                                                        

  3    10 mol%\                                                                                                                    CIPh              150       23(34)
       \[Rh(COD)Cl\]~2~                                                                                                                                        

  4    10 mol%\                                                                                                                    Xylenes           150       27(30)
       \[Rh(COD)Cl\]~2~                                                                                                                                        

  5    10 mol%\                                                                                                                    1,4-Dioxane       150       43(51)
       \[Rh(COD)Cl\]~2~                                                                                                                                        

  6    10 mol%\                                                  20 mol%\                                                          1,4-Dioxane       150       47(57)
       \[Rh(COD)Cl\]~2~                                          COD                                                                                           

  7    10 mol%\                                                  20 mol%\                                                          1,4-Dioxane       150       58(65)
       \[Rh(COD)Cl\]~2~                                          P(C~6~F~5~)~3~                                                                                

  8    10 mol%\                                                  10 mol%\                                                          1,4-Dioxane       150       67(74)
       \[Rh(COD)Cl\]~2~                                          P(3,5-C~6~H~3~(CF~3~)~2~)~3~                                                                  

  9    10 mol%\                                                  22 mol%\                                                          1,4-Dioxane       150       82
       \[Rh(COD)Cl\]~2~                                          P(3,5-C~6~H~3~(CF~3~)~2~)~3~                                                                  

  10   10 mol%\                                                  22 mol%\                                                          1,4-Dioxane       150       76(88)
       \[Rh(COD)Cl\]~2~[†](#TFN2){ref-type="table-fn"}           P(3,5-C~6~H~3~(CF~3~)~2~)~3~                                                                  

  11   **5 mol%**\                                               **24 mol%**\                                                      **1,4-Dioxane**   **150**   **87**
       **\[Rh(C~2~H~4~)~2~Cl\]~2~**                              **P(3,5-C~6~H~3~(CF~3~)~2~)~3~**[§](#TFN4){ref-type="table-fn"}                               

  12   5 mol%\                                                   24 mol%\                                                          1,4-Dioxane       150       0[‖](#TFN5){ref-type="table-fn"}
       \[Rh(C~2~H~4~)~2~Cl\]~2~[‡](#TFN3){ref-type="table-fn"}   P(3,5-C~6~H~3~(CF~3~)~2~)~3~[§](#TFN4){ref-type="table-fn"}                                   
  ---- --------------------------------------------------------- ----------------------------------------------------------------- ----------------- --------- ----------------------------------

Isolated yield; numbers in parentheses are brsm yield.

20 mol% **3** was used with 71 h reaction time.

no **3** was added.

The reaction time was 48 h.

Decarbonylation products were observed as an inseperable mixture.

###### 

Substrate Scope[\*](#TFN6){ref-type="table-fn"}

  --
  --

Reaction condition: \[Rh(C~2~H~4~)~2~Cl\]~2~ (5 mol%), P(3,5-C~6~H~3~(CF~3~)~2~)~3~ (24 mol%), **3** (100 mol%), 1,4-dioxane, 150 °C, 48 h.

Isolated yield; numbers in parentheses are brsm yield.

\[Rh(C~2~H~4~)~2~Cl\]~2~ (10 mol%) and P(3,5-C~6~H~3~(CF~3~)~2~)~3~ (48 mol%) were used.

24 h.
